In the clinical pathway for skin health, distinguishing between the tools used for diagnosis and those used for staging is fundamental for understanding your care. While medical imaging and laboratory tests provide essential data about the state of the body, they are not the primary methods used to confirm the presence of melanoma in a skin lesion. Instead, these advanced technologies are deployed strategically by healthcare teams to assess whether the cancer has moved beyond its original site and to monitor how the body is responding to treatment.
What We’ll Discuss in This Article
- Why a skin biopsy remains the gold standard for a primary diagnosis.
- The specific role of CT, MRI, and PET scans in identifying spread.
- How blood tests are used to monitor general health and organ function.
- The clinical significance of lactate dehydrogenase (LDH) levels.
- Identifying microscopic spread through sentinel lymph node biopsy.
- The purpose of staging scans for patients with high-risk melanoma.
- Future research into blood-based liquid biopsies for early detection.
The primary role of biopsy in melanoma diagnosis
A definitive diagnosis of melanoma cannot be made through a blood test or a scan; it requires the physical removal and microscopic analysis of the suspicious skin lesion. When a specialist identifies a concerning mole, they perform an excision biopsy to provide a tissue sample for a pathologist to examine. This microscopic review is the only way to confirm if cancer cells are present and to measure the specific characteristics of the tumour, such as its thickness. A primary diagnosis of melanoma is only confirmed through a histopathological examination of the skin tissue removed during a biopsy procedure. Scans and blood tests are considered secondary tools that follow this initial confirmation to help determine the overall stage of the disease.
Using scans to identify and confirm melanoma spread
Once a diagnosis of invasive melanoma is confirmed, various imaging scans may be used to look for signs that the cancer has spread to other parts of the body. Computed tomography (CT) scans use X-rays to create detailed images of the chest, abdomen, and pelvis to check for enlarged lymph nodes or lesions in organs like the lungs or liver. Magnetic resonance imaging (MRI) is frequently used to get high-resolution images of the brain and spine, which are common sites for melanoma spread in more advanced cases. These scans are essential for accurate staging but are generally not sensitive enough to identify the primary melanoma on the skin surface itself.
The function of blood tests in melanoma management
Blood tests are a standard part of the clinical toolkit, but their role is to assess your general health and monitor for complications rather than to detect the cancer itself. When you are diagnosed with melanoma, a doctor may order a full blood count and tests for kidney and liver function to ensure your body is healthy enough for surgery or systemic treatments. These tests provide a baseline that helps the medical team identify any changes that might occur during treatment. While they provide a snapshot of your internal health, a normal blood test result does not mean that melanoma is absent or has not spread.
Monitoring lactate dehydrogenase (LDH) levels
In cases of advanced melanoma, a specific blood test for an enzyme called lactate dehydrogenase (LDH) is often performed. LDH is released into the bloodstream when cells are damaged or destroyed, and high levels can sometimes be found when there is a significant amount of cancer in the body. While it is not a specific marker for melanoma, an elevated LDH level is a recognised prognostic factor used in the staging of Stage 4 disease. Clinical guidelines from NICE indicate that LDH levels should be measured as part of the staging process for patients with advanced or metastatic melanoma to help guide treatment planning. If LDH levels are normal, it is a positive sign, but it does not rule out the presence of smaller areas of spread.
Identifying microscopic spread through sentinel lymph node biopsy
While not a traditional scan or blood test, a sentinel lymph node biopsy (SLNB) is a specialised procedure used to check for the earliest signs of spread to the lymphatic system. This involves injecting a radioactive tracer and a blue dye near the site of the original melanoma to identify the first lymph node the cancer cells would likely reach. That node is then removed and checked under a microscope for microscopic traces of melanoma. This test is much more accurate than a standard CT or MRI scan for identifying very small amounts of cancer that have just begun to move beyond the skin.
The use of PET-CT scans for comprehensive staging
A positron emission tomography (PET) scan combined with a CT scan (PET-CT) is a highly sensitive imaging tool used to identify areas of active cancer growth throughout the entire body. Before the scan, a small amount of radioactive sugar is injected into a vein, which is then absorbed more quickly by cancer cells than by healthy cells. This allows the PET-CT to highlight suspicious areas that might not be clearly visible on a standard CT scan. In the UK, PET-CT is typically reserved for patients where there is a high suspicion of spread or to confirm the results of other imaging tests before starting complex treatments like immunotherapy.
Future developments in liquid biopsy research
Researchers in the UK are currently investigating the potential of liquid biopsies, which are advanced blood tests designed to detect circulating tumour DNA (ctDNA) in the bloodstream. These fragments of DNA are shed by cancer cells and can sometimes be identified even when a scan appears normal. By 2026, clinical trials are increasingly showing that monitoring ctDNA levels can help doctors identify if melanoma is returning much earlier than traditional imaging methods. While this technology is not yet a standard diagnostic tool for initial melanoma on the skin, it represents a significant step forward in the long-term surveillance of patients who have already been treated for high-risk disease.
Why scans are not used for initial screening
You might wonder why scans are not used as a routine way to screen for melanoma instead of a physical skin check. The reason is that early-stage melanoma is often only a few millimetres thick and is confined to the surface layers of the skin. Most imaging technologies, such as CT or MRI, have a limit to their resolution and cannot detect such small, superficial changes. Furthermore, scans expose the body to small amounts of radiation and can sometimes produce false positive results, leading to unnecessary anxiety and invasive procedures. Therefore, a visual inspection by a trained professional followed by a biopsy remains the safest and most accurate way to catch melanoma early.
The role of ultrasound in monitoring lymph nodes
Ultrasound is a non-invasive imaging tool that uses sound waves to create pictures of the tissues beneath the skin, particularly the lymph nodes in the neck, armpits, and groin. It is often used to monitor the lymph node basins in patients who have had a high-risk melanoma removed but did not undergo a sentinel lymph node biopsy. If an ultrasound shows that a lymph node has become enlarged or has an unusual shape, a fine-needle aspiration (FNA) can be performed under ultrasound guidance to take a small sample of the cells for testing. This provides a way to catch regional spread without the need for a general anaesthetic or more intensive surgery.
Conclusion
Blood tests and scans are powerful tools used by the NHS to stage melanoma and confirm spread, but they do not replace the biopsy for a primary diagnosis. While imaging like CT and MRI provides a view of the internal organs, and blood tests like LDH offer clues about disease activity, the gold standard remains the microscopic analysis of the skin itself. Understanding the specific purpose of each test helps in navigating the journey from diagnosis to treatment with clarity. If you experience severe, sudden, or worsening symptoms, call 999 immediately.
Can a normal blood test mean I do not have melanoma?
No, a standard blood test only checks your general health and organ function; it cannot detect the presence of melanoma on the skin.
Why did my doctor order a CT scan if my mole was already removed?
The CT scan is used to check if any melanoma cells moved into your internal organs or lymph nodes before the mole was taken out.
Is a PET scan better than a CT scan?
A PET scan is more sensitive at finding active cancer cells, but it is usually combined with a CT scan to provide a clearer picture of where those cells are located.
What is ctDNA?
It stands for circulating tumour DNA, which are tiny pieces of genetic material that cancer cells release into the blood, and is used in advanced research to track melanoma.
Will I have a scan for a very thin melanoma?
Usually no, as melanomas thinner than one millimetre have a very low risk of spread, so scans are generally not necessary according to clinical guidelines.
Does a high LDH level always mean cancer?
No, LDH can be raised due to many other conditions like infections or liver issues, so it is always interpreted alongside other clinical findings.
How often will I need scans after treatment?
The frequency of scans depends on the stage of your melanoma; high-risk patients may have them every six months for the first few years, while low-risk patients may not need them at all.
Authority Snapshot (E-E-A-T)
This article is designed to provide clear and factual information regarding skin health for the general public. The content is written by the Medical Content Team and has been reviewed by Dr. Stefan Petrov. He is a UK-trained physician with an MBBS and postgraduate certifications including Basic Life Support (BLS), Advanced Cardiac Life Support (ACLS), and the UK Medical Licensing Assessment (PLAB 1 & 2). He has hands-on experience in general medicine, surgery, anaesthesia, ophthalmology, and emergency care. Dr. Petrov has worked in both hospital wards and intensive care units, performing diagnostic and therapeutic procedures, and has contributed to medical education by creating patient-focused health content and teaching clinical skills to junior doctors.
